WKWM
ASMB icon

Walter & Keenan Wealth Management’s Assembly Biosciences ASMB Stock Holding History

Walter & Keenan Wealth Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,625
Closed -$284K – 148
2020
Q1 		$284K Buy
+1,625
New +$348K 0.11% 89

Other funds holding ASMB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walter & Keenan Wealth Management's ASMB Position: Q2 2020 in Review

Walter & Keenan Wealth Management sold out of Assembly Biosciences (ASMB) in Q2 2020, closing a stake of 1,625 shares — an estimated $284K sold.

Walter & Keenan Wealth Management first reported a position in ASMB in Q1 2020 and held it in 1 quarter. The position peaked at $284K in Q1 2020. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2020.

  • Walter & Keenan Wealth Management reported no remaining Assembly Biosciences position as of Q2 2020 after selling out during the quarter.
  • Walter & Keenan Wealth Management sold 1,625 Assembly Biosciences shares in Q2 2020, an estimated $284K.
  • Walter & Keenan Wealth Management first reported a position in Assembly Biosciences in Q1 2020 and held it in 1 quarter.
  • Walter & Keenan Wealth Management's Assembly Biosciences position peaked at $284K in Q1 2020.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2020.

Based on Walter & Keenan Wealth Management's 13F filing for Q2 2020, filed 16 Jul 2020.